13 December 2022

REIG JOFRE has successfully completed the co-development of TRIFERTY-ATM®, a food supplement that contributes to male fertility

8 November 2022

REIG JOFRE launches a medicinal nail lacquer for onychomycosis with Ciclotech® the new patented trans-ungueal release technology

2 November 2022

REIG JOFRE submits press release on the global license agreement reached by Syna Therapeutics

28 October 2022

REIG JOFRE submits results note on third quarter of 2022

7 September 2022

FORTÉ PHARMA, REIG JOFRE’s brand of food supplements launches its E-commerce in China

26 July 2022

Reig Jofre submits results note on second quarter of 2022

25 July 2022

Reig Jofre informs on the start date of the trading of the new shares within its scrip dividend

12 July 2022

Reig Jofre informs on the bonus-shares capital increase and the new shares to be issued for its scrip dividend

14 June 2022

Execution of the scrip dividend

9 June 2022

Reig Jofre informs on the Scrip Dividend Conditions

23 May 2022

Reig Jofre launches Regenail® topical solution for structural nail alterations

28 February 2022

Reig Jofre submits results note on fourth quarter of 2021

15 November 2021

Bioglan and Stada partner to increase capacity to meet rising demand for Parkinson’s treatment

29 October 2021

Reig Jofre submits results note on third quarter of 2021

29 July 2021

Reig Jofre submits results note on second quarter of 2021

22 July 2021

Reig Jofre acquires 100% of REIG JOFRE UK LTD and consolidates its presence in the United Kingdom

21 July 2021

Start of the trading of the new shares within its scrip dividend

6 July 2021

Start of the second temporary share buyback program

6 July 2021

Increase in the bonus-share capital and new shares to be issued

5 July 2021

Completion of the liquidity contract